Veröffentlichungen

  • De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study.Lancet Oncol, 2014;15:23-24
  • Heublein S, Grasse K, Hessel H, Burges A, Lenhard M, Engel J, Kirchner T, Jeschke U, Mayr D. KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.BMC, 2013;13:483
  • Engel J, Schlesinger-Raab A, Emeny R, Hölzel D, Schubert-Fritschle G. Quality of Life in Woman with Localized Breast Cancer or Malignant Melanoma 2 Years after Initial Treatment: a Comparison. Int J Behav, 2013; [Epub ahead of print]
  • Engel J, Emeny RT, Hölzel D. Positive lymph nodes do not metastasize.Cancer Metastasis Rev 2012 Jun;31:235-46
  • Engel J, Bastian PJ, Baur H, Beer V, Chaussy C, Gschwend JE, Oberneder R, Rothenberger KH, Stief CG, Hölzel D. Survival Benefit of Radical Prostatectomy in Lymph Node-Positive Patients with Prostate Cancer. Eur Urol 2010;57:754-761